Vanguard Group’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.5M | Buy |
2,802,039
+247,815
| +10% | +$1.64M | ﹤0.01% | 2592 |
|
|
2025
Q1 | $23.4M | Buy |
2,554,224
+92,143
| +4% | +$843K | ﹤0.01% | 2440 |
|
|
2024
Q4 | $25.9M | Buy |
2,462,081
+388,174
| +19% | +$4.08M | ﹤0.01% | 2463 |
|
|
2024
Q3 | $24.8M | Buy |
2,073,907
+413,241
| +25% | +$4.94M | ﹤0.01% | 2485 |
|
|
2024
Q2 | $9.55M | Buy |
1,660,666
+442,166
| +36% | +$2.54M | ﹤0.01% | 2956 |
|
|
2024
Q1 | $6.34M | Hold |
1,218,500
| – | – | ﹤0.01% | 3199 |
|
|
2023
Q4 | $6.42M | Buy |
1,218,500
+17,420
| +1% | +$91.8K | ﹤0.01% | 3185 |
|
|
2023
Q3 | $3.96M | Buy |
1,201,080
+5,668
| +0.5% | +$18.7K | ﹤0.01% | 3343 |
|
|
2023
Q2 | $3.45M | Sell |
1,195,412
-136,020
| -10% | -$393K | ﹤0.01% | 3466 |
|
|
2023
Q1 | $1.42M | Sell |
1,331,432
-14,899
| -1% | -$15.9K | ﹤0.01% | 3796 |
|
|
2022
Q4 | $3.51M | Buy |
1,346,331
+162,425
| +14% | +$424K | ﹤0.01% | 3455 |
|
|
2022
Q3 | $8.29M | Buy |
1,183,906
+191,671
| +19% | +$1.34M | ﹤0.01% | 3053 |
|
|
2022
Q2 | $6.77M | Sell |
992,235
-128,829
| -11% | -$878K | ﹤0.01% | 3202 |
|
|
2022
Q1 | $15.8M | Sell |
1,121,064
-435,365
| -28% | -$6.14M | ﹤0.01% | 2905 |
|
|
2021
Q4 | $22.6M | Buy |
1,556,429
+752,650
| +94% | +$10.9M | ﹤0.01% | 2772 |
|
|
2021
Q3 | $11.4M | Buy |
803,779
+286,286
| +55% | +$4.05M | ﹤0.01% | 3163 |
|
|
2021
Q2 | $9.11M | Buy |
517,493
+303,495
| +142% | +$5.34M | ﹤0.01% | 3256 |
|
|
2021
Q1 | $3.27M | Buy |
+213,998
| New | +$3.27M | ﹤0.01% | 3726 |
|